TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
XNCR

Xencor Inc

Healthcare · Biotechnology

24.60$ +3.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Xencor Inc (XNCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 126 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement XNCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
9.5 28 88 36 41 157 123 275 165 168 110 126
19 34 52 72 98 119 170 7.5 8.8 254 228 11
-9.0 28 88 36 41 38 123 275 165 -85 -117 115
19 34 52 72 98 119 170 193 200 254 228 239
7.5 12 13 18 22 24 30 39 47 53 50 64
26 46 65 89 120 24 199 231 247 307 61 293
-16 -18 23 -54 -79 14 -77 44 -82 -139 -178 -178
0.0 0.0 0.0 0.0 0.0 18 0.0 7.5 37 6.2 37 32
-16 -18 25 -49 -70 27 -69 83 -55 -120 -235 -89
-0.8 -1.1 1.0 -0.5 9.0 0.3 -5.8 -7.5 0.7 5.8 1.6 2.5
-16 -18 24 -49 -70 27 -64 83 -55 -126 -233 -92
-16 -17 24 -52 -76 18 -71 51 -74 -126 -186 -47

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?